Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-14

FDA Approved: BEPOTASTINE BESILATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved the original application for bepotastine besilate, a generic antihistamine for allergic conjunctivitis, submitted by Somerset Therapeutics, LLC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bepotastine besilate (Bepotastine besilate)

Snippet

ORIG AP for BEPOTASTINE BESILATE (BEPOTASTINE BESILATE)